Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Dr Andrew A. Parsons

Dr Andrew A. Parsons

Director of Reciprocal Minds Limited & Chairman of Pharmasum Therapeutics AS

Connect with Dr Andrew A. Parsons on LinkedIn
Website:

About the author:

Dr Andrew A Parsons initially trained as a Pharmacologist and Neuroscientist and has over 90 peer reviewed publications, several patents and contributed to Educational Books in Science and Medicine. His former scientific focus was in areas of neuroplasticity and neurodegeneration. He played key roles on individual projects from initial idea through development and the market place. Working across traditional organisational and cultural boundaries he was instrumental in creating External Innovation platforms within a large Pharma company. Through this he became interested the impact of Human Factors on operational processes. He is a member of the Pharmaceutical Special Interest group and an associate member of the Chartered Institute of Ergonomics and Human Factors.

He is the Director of Reciprocal Minds Limited which supports individuals and groups undergoing personal and professional development and challenges to health and wellbeing. He is the co-author of “Leading with Presence, what it is, why it matters and how to get it?” He is also the Chairman of Pharmasum Therapeutics AS, an early stage Biotech company.


Posts by Dr Andrew A. Parsons

Cost Saving: The trade-off that bites back

Posted on April 3rd, 2017 in Pharma R&D

Making a trade-off between competing activities or priorities is a critical skill involved in developing a new medicine. This approach helps balance the risk of technical failure and investment to develop innovative products, an important consideration with such high failure rates in pharma R&D. Continue reading “Cost Saving: The trade-off that bites back” »

The Change Imperative: Finding the right balance as times change

Posted on March 27th, 2017 in Pharmacovigilance

I was delighted to chair a CPD Pharmacovigilance meeting last week in Berlin. I had been asked to share perspectives from the discussions within the Pharmaceutical Special Interest group at the Chartered Institute of Ergonomics and Human Factors. Continue reading “The Change Imperative: Finding the right balance as times change” »

Humans: What we say and think does not always predict what we do

Posted on March 22nd, 2017 in Pharma R&D

 

Actions speak louder than words. This is a useful adage and was a family mantra. It has been useful to keep this in mind in so many situations, in both my personal and professional life. Continue reading “Humans: What we say and think does not always predict what we do” »

Clean food, gut bacteria, and drug effects: Is diet another variable drug development?

Posted on March 9th, 2017 in Pharma R&D

There has been quite a lot of press coverage in the UK recently regarding clean eating, and a variety of recipes and websites offering advice are becoming quite popular. Continue reading “Clean food, gut bacteria, and drug effects: Is diet another variable drug development?” »

  1. 1
  2. 2
  3. 3
  4. 4